Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 88 for “"Immune checkpoints"”.
-
Targeting immune checkpoints in breast cancer.
Immune checkpoints are regulators of immune activation that can be triggered to suppress the immune response against tumours. Immune checkpoint inhibitors (ICIs) have shown efficacy in a variety of cancer types, but in the majority of cancer types only a minority of patients respond. The aim of …
-
Modulation of Immune Checkpoints by Tumour Extracellular Vesicles
… features and can condition immunity, favouring immune escape. Immune checkpoints (IC), expressed by immune and cancerous cells, regulate immune responses. BRAF and MEK inhibitors, a standard treatment for BRAF-mutated melanoma patients, can condition tumour cell IC expression. I investigated the …
-
Immune checkpoints as gatekeepers of CD8+ T cell differentiation
Immune checkpoint inhibition represents a promising approach for multiple malignancies. Why successful T cell responses are achieved in only some patients is not well understood. We investigated how combined loss of PD-1 and LAG-3 signaling in CD8+ T cells would influence a well-characterized …
-
Haploid genetic screening approach towards identifying novel regulators of immune checkpoints
<p>Priming the immune system by blockade of immune checkpoint proteins has revolutionized cancer therapy and achieved durable clinical responses. Despite the success of targeting the PD1-PDL1 axis or CTLA-4 to release the breaks on T cells, the response across cancer types and patients has not been …
-
Rebalancing immune checkpoints in rheumatoid arthritis by targeting the synovial microenvironment
… TNC-rich areas contained significantly more immune cells, particularly macrophages, compared to TNC-poor areas. GPNMB, a poorly studied immunomodulatory protein, was down-regulated in TNC-rich areas. GPNMB is expressed in the lining layer on remission-associated macrophages, and we confirmed …
-
Harnessing dendritic cells and immune checkpoints to boost graft-versus-tumor immunity
Radboud University, 18 mei 2018
-
The influence of immune checkpoints on Blinatumomab-mediated effects on primary T cells
… relapse. Since the upregulation of inhibitory immune checkpoints on tumor cells represents a highly effective mechanism to undermine endogenous cancer immunosurveillance, further investigation of the immune-suppressive influence of inhibitory immune checkpoints on Blinatumomab-mediated …
-
The Design and Synthesis of Peptides and Small Molecules to Control Immune Checkpoints
… small molecule and peptide inhibitors for the immune checkpoint protein-protein interaction, programmed cell death 1 and programmed cell death ligand 1 (PD-1/PD-L1). The discovery of PD-1/PD-L1 has been invaluable to the effectiveness of immunotherapy treatment for cancer. In chapter one the …
-
BET bromodomain proteins regulate immune checkpoints through both AMPK-dependent and independent pathways
Immune exhaustion can be a major clinical problem for patients who have cancer or chronic inflammation. Persistent antigen stimulation drives T cells to express multiple surface markers called immune checkpoints. When these markers bind to their corresponding ligands that are expressed by antigen …
-
Developing nucleic acid-based therapies targeting immune checkpoints in glioblastoma microenvironment using lipid nanoparticles
… Unlike melanoma and several other solid tumours, immune checkpoint blockade targeting PD-1/PD-L1 or CTLA-4 has shown limited clinical benefit in glioblastoma, highlighting the need to identify alternative immune regulatory pathways and develop strategies capable of overcoming the tumour’s immune …
-
Guided tumor ablation and targeted delivery of innate immune checkpoints to enhance cancer immunotherapy
Radboud University, 25 juni 2025
-
Exploring Immune Checkpoints and Cytokine Signaling to Improve NK Cell Effector Function in Ovarian Cancer
The demonstration that ovarian carcinoma (OC) is an immunogenic disease, opens opportunities to explore immunotherapeutic interventions to improve clinical outcome. In this regard, NK cell based immunotherapy could be promising as it has been demonstrated that OC cells are susceptible to killing by …
-
CANCER THERAPY THROUGH TLR-INDUCED LOCAL INNATE IMMUNITY ACTIVATION AND BLOCK OF IMMUNE CHECKPOINTS OR SUPPRESSIVE CELLS
… microenvironment more favorable to induce an immune response against lung primary cancer and/or metastases. Aim of this thesis is the evaluation of strategies to improve the antitumor activity of aerosolized TLR9 agonist in the lung. The thesis is divided in three tasks: 1) the evaluation of …
-
Approach using "second-generation" immune checkpoint inhibitors for the treatment of triple-negative breast cancer
… the blockade of novel “second generation” immune checkpoints could be promising to enhance the number of responders. This project aims at highlighting new immune checkpoints of particular interest in the context of TNBC and studying the impact of their inhibition on TNBC progression. To …
-
LAG3 expression profile and the mechanisms regulating LAG3 expression and function
During persistent activation of immune cells, immune checkpoints are upregulated and inhibit the cell function. While potentially desirable for autoimmunity and excessive immune activation, immune checkpoints are harmful during cancer and potentially harmful during infection. Immune checkpoint …
-
THE ROLE OF HISTONE ACETYLATION IN THE CONTROL OF IMMUNE CHECKPOINT EXPRESSION IN CD8+ T CELLS
… is characterized by the expression of multiple immune checkpoint molecules on the surface of T cells and loss of effector functions. Epigenetic programs governing the coordinate expression of immune checkpoints and the implications of different patterns of checkpoint expression on T cell …
-
Antigen regulation of t cell receptor signalling and immune checkpoint expression in health and disease
… dose and affinity, as well as over-expression of immune checkpoints in the tumour microenvironment (TME) affect such processes. The novel Nr4a3-Timer of cell kinetics and activity (Tocky) system was used for the temporal analysis of CD8+ T cell activation through distal TCR signalling analyses. It …
-
Parp Inhibitor Upregulates Pd-L1 Expression and Enhances Cancer-Associated Immunosuppression
… antibodies that block CTLA4, PD-1 and PD-L1, immune checkpoints have emerged as new targets in cancer therapy. In addition, there is accumulating evidence highlighting the role of cancer-associated immunity in patient response to cytotoxic anticancer agents. Inhibitors of poly (ADP-ribose) …
-
Development of novel antibodies blocking the CD47-SIRPα myeloid-specific immune checkpoint as an improved strategy for Acute Myeloid Leukemia immunotherapy
… immunotherapy, especially targeting immune checkpoints, have revolutionized cancer treatment. Immune checkpoints are inhibitory pathways responsible for dampening the immune response in order to ensure self-tolerance under physiological conditions. In cancer cells, however, immune …
Page 1 of 5